Skip to main content
Erschienen in: Current Cardiovascular Imaging Reports 3/2010

01.06.2010

Recent Developments in Outcomes Research in Cardiovascular MRI

verfasst von: Caroline Daly, Otavio R. Coelho-Filho, Raymond Y. Kwong

Erschienen in: Current Cardiovascular Imaging Reports | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Since the start of this millennium, cardiovascular MRI (CMR) has made large strides toward technical optimization, and the impressive range and capability afforded by CMR has gained its widespread acceptance as the gold standard cardiac imaging technique for a range of diagnostic indications. Such has been the pace of developments in the field, both software and hardware related, that for the initial years of this decade the focus of most research was on novel techniques and applications. However, as these techniques have become refined and established, and the technique has become more widely available in clinical settings, there is a growing body of work addressing the prognostic implications of CMR findings. This article explores recent developments in the evaluation of clinical outcomes according to CMR and how this builds on our current knowledge in the field.
Literatur
1.
Zurück zum Zitat •• Bruder O, Schneider S, Nothnagel D, et al.: EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009, 54:1457–1466. This key study demonstrated the utility of CMR across a wide range of clinical settings in over 11,000 patients.CrossRefPubMed •• Bruder O, Schneider S, Nothnagel D, et al.: EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol 2009, 54:1457–1466. This key study demonstrated the utility of CMR across a wide range of clinical settings in over 11,000 patients.CrossRefPubMed
2.
Zurück zum Zitat Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992–2002.PubMed Kim RJ, Fieno DS, Parrish TB, et al.: Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999, 100:1992–2002.PubMed
3.
Zurück zum Zitat Simonetti OP, Kim RJ, Fieno DS, et al.: An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001, 218:215–223.PubMed Simonetti OP, Kim RJ, Fieno DS, et al.: An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001, 218:215–223.PubMed
4.
Zurück zum Zitat Rehwald WG, Fieno DS, Chen EL, et al.: Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002, 105:224–229.CrossRefPubMed Rehwald WG, Fieno DS, Chen EL, et al.: Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002, 105:224–229.CrossRefPubMed
5.
Zurück zum Zitat Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445–1453.CrossRefPubMed Kim RJ, Wu E, Rafael A, et al.: The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000, 343:1445–1453.CrossRefPubMed
6.
Zurück zum Zitat Kuhl HP, Lipke CS, Krombach GA, et al.: Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006, 27:846–853.CrossRefPubMed Kuhl HP, Lipke CS, Krombach GA, et al.: Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J 2006, 27:846–853.CrossRefPubMed
7.
Zurück zum Zitat Klein C, Nekolla SG, Bengel FM, et al.: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002, 105:162–167.CrossRefPubMed Klein C, Nekolla SG, Bengel FM, et al.: Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002, 105:162–167.CrossRefPubMed
8.
Zurück zum Zitat Selvanayagam JB, Kardos A, Francis JM, et al.: Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004, 110:1535–1541.CrossRefPubMed Selvanayagam JB, Kardos A, Francis JM, et al.: Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization. Circulation 2004, 110:1535–1541.CrossRefPubMed
9.
Zurück zum Zitat Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733–2743.CrossRefPubMed Kwong RY, Chan AK, Brown KA, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733–2743.CrossRefPubMed
10.
Zurück zum Zitat Kwon DH, Halley CM, Carrigan TP, et al.: Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009, 2:34–44.CrossRefPubMed Kwon DH, Halley CM, Carrigan TP, et al.: Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009, 2:34–44.CrossRefPubMed
11.
Zurück zum Zitat Kwong RY, Sattar H, Wu H, et al.: Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008, 118:1011–1020.CrossRefPubMed Kwong RY, Sattar H, Wu H, et al.: Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008, 118:1011–1020.CrossRefPubMed
12.
Zurück zum Zitat • Steel K, Broderick R, Gandla V, et al.: Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009, 120:1390–1400. This important study demonstrated the separate and complementary nature of prognostic information obtained from documentation of reversible ischemia and pre-existing infarction.CrossRefPubMed • Steel K, Broderick R, Gandla V, et al.: Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009, 120:1390–1400. This important study demonstrated the separate and complementary nature of prognostic information obtained from documentation of reversible ischemia and pre-existing infarction.CrossRefPubMed
13.
Zurück zum Zitat Rahimi K, Banning AP, Cheng AS, et al.: Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart 2009, 95:1937–1943.CrossRefPubMed Rahimi K, Banning AP, Cheng AS, et al.: Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart 2009, 95:1937–1943.CrossRefPubMed
14.
Zurück zum Zitat • Cheong BY, Muthupillai R, Wilson JM, et al.: Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009, 120:2069–2076. This is the largest study to date that confirms the prognostic importance of late gadolinium enhancement in unselected patients with and without ischemic heart disease.CrossRefPubMed • Cheong BY, Muthupillai R, Wilson JM, et al.: Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009, 120:2069–2076. This is the largest study to date that confirms the prognostic importance of late gadolinium enhancement in unselected patients with and without ischemic heart disease.CrossRefPubMed
15.
Zurück zum Zitat Seeger A, Fenchel M, Kramer U, et al.: Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography. Eur Radiol 2009, 20:838–845 .CrossRefPubMed Seeger A, Fenchel M, Kramer U, et al.: Towards risk stratification in systemic atherosclerosis: value of myocardial function and viability imaging as an adjunct to MR angiography. Eur Radiol 2009, 20:838–845 .CrossRefPubMed
16.
Zurück zum Zitat Yan AT, Shayne AJ, Brown KA, et al.: Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32–39.CrossRefPubMed Yan AT, Shayne AJ, Brown KA, et al.: Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32–39.CrossRefPubMed
17.
Zurück zum Zitat Schmidt A, Azevedo CF, Cheng A, et al.: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006–2014.CrossRefPubMed Schmidt A, Azevedo CF, Cheng A, et al.: Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007, 115:2006–2014.CrossRefPubMed
18.
Zurück zum Zitat • Roes SD, Borleffs CJ, van der Geest RJ, et al.: Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009, 2:183–190. This most recent publication, following on from references 16 and 17 above, highlights the importance of the peri-infarct zone in determining the risk of arrhythmic events in post-infarction patients.CrossRefPubMed • Roes SD, Borleffs CJ, van der Geest RJ, et al.: Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009, 2:183–190. This most recent publication, following on from references 16 and 17 above, highlights the importance of the peri-infarct zone in determining the risk of arrhythmic events in post-infarction patients.CrossRefPubMed
19.
Zurück zum Zitat McCrohon JA, Moon JC, Prasad SK, et al.: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54–59.CrossRefPubMed McCrohon JA, Moon JC, Prasad SK, et al.: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003, 108:54–59.CrossRefPubMed
20.
Zurück zum Zitat Assomull RG, Prasad SK, Lyne J, et al.: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977–1985.CrossRefPubMed Assomull RG, Prasad SK, Lyne J, et al.: Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006, 48:1977–1985.CrossRefPubMed
21.
Zurück zum Zitat •• Wu KC, Weiss RG, Thiemann DR, et al.: Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008, 51:2414–2421. Late gadolinium enhancement is not always present in nonischemic dilated cardiomyopathy, but when it is, it portends a worse prognosis.CrossRefPubMed •• Wu KC, Weiss RG, Thiemann DR, et al.: Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 2008, 51:2414–2421. Late gadolinium enhancement is not always present in nonischemic dilated cardiomyopathy, but when it is, it portends a worse prognosis.CrossRefPubMed
22.
Zurück zum Zitat Hombach V, Merkle N, Torzewski J, et al.: Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009, 30:2011–2018.CrossRefPubMed Hombach V, Merkle N, Torzewski J, et al.: Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2009, 30:2011–2018.CrossRefPubMed
23.
Zurück zum Zitat Messroghli DR, Plein S, Higgins DM, et al.: Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study. Radiology 2006, 238:1004–1012.CrossRefPubMed Messroghli DR, Plein S, Higgins DM, et al.: Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study. Radiology 2006, 238:1004–1012.CrossRefPubMed
24.
Zurück zum Zitat Iles L, Pfluger H, Phrommintikul A, et al.: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008, 52:1574–1580.CrossRefPubMed Iles L, Pfluger H, Phrommintikul A, et al.: Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008, 52:1574–1580.CrossRefPubMed
25.
Zurück zum Zitat Rickers C, Wilke NM, Jerosch-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855–861.CrossRefPubMed Rickers C, Wilke NM, Jerosch-Herold M, et al.: Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005, 112:855–861.CrossRefPubMed
26.
Zurück zum Zitat Maron MS, Maron BJ, Harrigan C, et al.: Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009, 54:220–228.CrossRefPubMed Maron MS, Maron BJ, Harrigan C, et al.: Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009, 54:220–228.CrossRefPubMed
27.
Zurück zum Zitat Moon JC, McKenna WJ, McCrohon JA, et al.: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561–1567.CrossRefPubMed Moon JC, McKenna WJ, McCrohon JA, et al.: Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003, 41:1561–1567.CrossRefPubMed
28.
Zurück zum Zitat Maron MS, Appelbaum E, Harrigan CJ, et al.: Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008, 1:184–191.CrossRefPubMed Maron MS, Appelbaum E, Harrigan CJ, et al.: Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008, 1:184–191.CrossRefPubMed
29.
Zurück zum Zitat Adabag AS, Maron BJ, Appelbaum E, et al.: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369–1374.CrossRefPubMed Adabag AS, Maron BJ, Appelbaum E, et al.: Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 2008, 51:1369–1374.CrossRefPubMed
30.
Zurück zum Zitat O’Hanlon R, Grasso A, Groughton M, al.: Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010, 12(Suppl 1):O50.CrossRef O’Hanlon R, Grasso A, Groughton M, al.: Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010, 12(Suppl 1):O50.CrossRef
31.
Zurück zum Zitat Rubinshtein R, Glockner JF, Ommen SR, et al.: Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010, 3:51–58.CrossRefPubMed Rubinshtein R, Glockner JF, Ommen SR, et al.: Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 2010, 3:51–58.CrossRefPubMed
32.
Zurück zum Zitat Sen-Chowdhry S, Syrris P, Ward D, et al.: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115:1710–1720.CrossRefPubMed Sen-Chowdhry S, Syrris P, Ward D, et al.: Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115:1710–1720.CrossRefPubMed
33.
Zurück zum Zitat Tandri H, Castillo E, Ferrari VA, et al.: Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006, 48:2277–2284.CrossRefPubMed Tandri H, Castillo E, Ferrari VA, et al.: Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006, 48:2277–2284.CrossRefPubMed
34.
Zurück zum Zitat Tandri H, Saranathan M, Rodriguez ER, et al.: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98–103.CrossRefPubMed Tandri H, Saranathan M, Rodriguez ER, et al.: Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005, 45:98–103.CrossRefPubMed
35.
Zurück zum Zitat Patel MR, Cawley PJ, Heitner JF, et al.: Detection of myocardial damage in patients with sarcoidosis. Circulation 2009, 120:1969–1977.CrossRefPubMed Patel MR, Cawley PJ, Heitner JF, et al.: Detection of myocardial damage in patients with sarcoidosis. Circulation 2009, 120:1969–1977.CrossRefPubMed
36.
Zurück zum Zitat Maceira AM, Prasad SK, Hawkins PN, et al.: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008, 10:54.CrossRefPubMed Maceira AM, Prasad SK, Hawkins PN, et al.: Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 2008, 10:54.CrossRefPubMed
37.
Zurück zum Zitat Grothues F, Smith GC, Moon JC, et al.: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29–34.CrossRefPubMed Grothues F, Smith GC, Moon JC, et al.: Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29–34.CrossRefPubMed
38.
Zurück zum Zitat Flynn M, Curtin R, Nowicki ER, et al.: Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: a pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg 2009, 137:1063–70e2. Flynn M, Curtin R, Nowicki ER, et al.: Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: a pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg 2009, 137:1063–70e2.
39.
Zurück zum Zitat Weidemann F, Herrmann S, Stork S, et al.: Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009, 120:577–584.CrossRefPubMed Weidemann F, Herrmann S, Stork S, et al.: Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009, 120:577–584.CrossRefPubMed
40.
Zurück zum Zitat • Lockie T, Nagel E, Redwood S, Plein S: Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation 2009, 119:1671–1681. This is an excellent review of the utility of CMR in acute coronary syndromes, ranging from infarct sizing and assessment of microvascular obstruction to risk stratification in intermediate-risk chest pain using stress techniques.CrossRefPubMed • Lockie T, Nagel E, Redwood S, Plein S: Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation 2009, 119:1671–1681. This is an excellent review of the utility of CMR in acute coronary syndromes, ranging from infarct sizing and assessment of microvascular obstruction to risk stratification in intermediate-risk chest pain using stress techniques.CrossRefPubMed
41.
Zurück zum Zitat Eitel I, Desch S, Sareban M, et al.: Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty. Am Heart J 2009, 158:806–813.CrossRefPubMed Eitel I, Desch S, Sareban M, et al.: Prognostic significance and magnetic resonance imaging findings in aborted myocardial infarction after primary angioplasty. Am Heart J 2009, 158:806–813.CrossRefPubMed
42.
Zurück zum Zitat Kumar A, Abdel-Aty H, Kriedemann I, et al.: Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 2006, 48:1969–1976.CrossRefPubMed Kumar A, Abdel-Aty H, Kriedemann I, et al.: Contrast-enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 2006, 48:1969–1976.CrossRefPubMed
43.
Zurück zum Zitat Larose E, Ganz P, Reynolds HG, et al.: Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007, 49:855–862.CrossRefPubMed Larose E, Ganz P, Reynolds HG, et al.: Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 2007, 49:855–862.CrossRefPubMed
44.
Zurück zum Zitat Roes SD, Kelle S, Kaandorp TA, et al.: Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007, 100:930–936.CrossRefPubMed Roes SD, Kelle S, Kaandorp TA, et al.: Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007, 100:930–936.CrossRefPubMed
45.
Zurück zum Zitat Wu E, Ortiz JT, Tejedor P, et al.: Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008, 94:730–736.CrossRefPubMed Wu E, Ortiz JT, Tejedor P, et al.: Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008, 94:730–736.CrossRefPubMed
46.
Zurück zum Zitat Bogaert J, Kalantzi M, Rademakers FE, et al.: Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 2007, 17:2572–2580.CrossRefPubMed Bogaert J, Kalantzi M, Rademakers FE, et al.: Determinants and impact of microvascular obstruction in successfully reperfused ST-segment elevation myocardial infarction. Assessment by magnetic resonance imaging. Eur Radiol 2007, 17:2572–2580.CrossRefPubMed
47.
Zurück zum Zitat Nijveldt R, Beek AM, Hirsch A, et al.: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008, 52:181–189.CrossRefPubMed Nijveldt R, Beek AM, Hirsch A, et al.: Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008, 52:181–189.CrossRefPubMed
48.
Zurück zum Zitat Nijveldt R, Beek AM, Hirsch A, et al.: ‘No-reflow’ after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR. Neth Heart J 2008, 16:179–181.PubMed Nijveldt R, Beek AM, Hirsch A, et al.: ‘No-reflow’ after acute myocardial infarction: direct visualisation of microvascular obstruction by gadolinium-enhanced CMR. Neth Heart J 2008, 16:179–181.PubMed
49.
Zurück zum Zitat Bodi V, Sanchis J, Nunez J, et al.: Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging 2009, 2:835–842.CrossRefPubMed Bodi V, Sanchis J, Nunez J, et al.: Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging 2009, 2:835–842.CrossRefPubMed
50.
Zurück zum Zitat Niccoli G, Burzotta F, Galiuto L, Crea F: Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54:281–292.CrossRefPubMed Niccoli G, Burzotta F, Galiuto L, Crea F: Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54:281–292.CrossRefPubMed
51.
Zurück zum Zitat Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765–772.PubMed Wu KC, Zerhouni EA, Judd RM, et al.: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998, 97:765–772.PubMed
52.
Zurück zum Zitat Hombach V, Grebe O, Merkle N, et al.: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005, 26:549–557.CrossRefPubMed Hombach V, Grebe O, Merkle N, et al.: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005, 26:549–557.CrossRefPubMed
53.
Zurück zum Zitat Bruder O, Breuckmann F, Jensen C, et al.: Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the “Herzinfarktverbund Essen.” Herz 2008, 33:136–142.CrossRefPubMed Bruder O, Breuckmann F, Jensen C, et al.: Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the “Herzinfarktverbund Essen.” Herz 2008, 33:136–142.CrossRefPubMed
54.
Zurück zum Zitat Cochet AA, Lorgis L, Lalande A, et al.: Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol 2009, 19:2117–2126.CrossRefPubMed Cochet AA, Lorgis L, Lalande A, et al.: Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol 2009, 19:2117–2126.CrossRefPubMed
55.
Zurück zum Zitat Kwong RY, Schussheim AE, Rekhraj S, et al.: Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003, 107:531–537.CrossRefPubMed Kwong RY, Schussheim AE, Rekhraj S, et al.: Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation 2003, 107:531–537.CrossRefPubMed
56.
Zurück zum Zitat Ingkanisorn WP, Kwong RY, Bohme NS, et al.: Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006, 47:1427–1432.CrossRefPubMed Ingkanisorn WP, Kwong RY, Bohme NS, et al.: Prognosis of negative adenosine stress magnetic resonance in patients presenting to an emergency department with chest pain. J Am Coll Cardiol 2006, 47:1427–1432.CrossRefPubMed
57.
Zurück zum Zitat Lerakis S, McLean DS, Anadiotis AV, et al.: Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain. J Cardiovasc Magn Reson 2009, 11:37.CrossRefPubMed Lerakis S, McLean DS, Anadiotis AV, et al.: Prognostic value of adenosine stress cardiovascular magnetic resonance in patients with low-risk chest pain. J Cardiovasc Magn Reson 2009, 11:37.CrossRefPubMed
58.
Zurück zum Zitat Greenwood JP, Younger JF, Ridgway JP, et al.: Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart 2007, 93:1363–1368.CrossRefPubMed Greenwood JP, Younger JF, Ridgway JP, et al.: Safety and diagnostic accuracy of stress cardiac magnetic resonance imaging vs exercise tolerance testing early after acute ST elevation myocardial infarction. Heart 2007, 93:1363–1368.CrossRefPubMed
59.
Zurück zum Zitat Nandalur KR, Dwamena BA, Choudhri AF, et al.: Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 2007, 50:1343–1353.CrossRefPubMed Nandalur KR, Dwamena BA, Choudhri AF, et al.: Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis. J Am Coll Cardiol 2007, 50:1343–1353.CrossRefPubMed
60.
Zurück zum Zitat Schwitter J, Wacker CM, van Rossum AC, et al.: MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008, 29:480–489.CrossRefPubMed Schwitter J, Wacker CM, van Rossum AC, et al.: MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008, 29:480–489.CrossRefPubMed
61.
Zurück zum Zitat •• Jahnke C, Nagel E, Gebker R, et al.: Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007, 115:1769–1776. This key publication documents the prognostic value of stress magnetic resonance, including both vasodilator and dobutamine stress.CrossRefPubMed •• Jahnke C, Nagel E, Gebker R, et al.: Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007, 115:1769–1776. This key publication documents the prognostic value of stress magnetic resonance, including both vasodilator and dobutamine stress.CrossRefPubMed
62.
Zurück zum Zitat Hundley WG, Morgan TM, Neagle CM, et al.: Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002, 106:2328–2333.CrossRefPubMed Hundley WG, Morgan TM, Neagle CM, et al.: Magnetic resonance imaging determination of cardiac prognosis. Circulation 2002, 106:2328–2333.CrossRefPubMed
63.
Zurück zum Zitat Bodi V, Sanchis J, Lopez-Lereu MP, et al.: Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2007, 50:1174–1179.CrossRefPubMed Bodi V, Sanchis J, Lopez-Lereu MP, et al.: Prognostic value of dipyridamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol 2007, 50:1174–1179.CrossRefPubMed
64.
Zurück zum Zitat Dall’Armellina E, Morgan TM, Mandapaka S, et al.: Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol 2008, 52:279–286.CrossRefPubMed Dall’Armellina E, Morgan TM, Mandapaka S, et al.: Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. J Am Coll Cardiol 2008, 52:279–286.CrossRefPubMed
65.
Zurück zum Zitat Wellnhofer E, Olariu A, Klein C, et al.: Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004, 109:2172–2174.CrossRefPubMed Wellnhofer E, Olariu A, Klein C, et al.: Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004, 109:2172–2174.CrossRefPubMed
66.
Zurück zum Zitat Kelle S, Roes SD, Klein C, et al.: Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009, 54:1770–1777.CrossRefPubMed Kelle S, Roes SD, Klein C, et al.: Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009, 54:1770–1777.CrossRefPubMed
67.
Zurück zum Zitat Wallace EL, Morgan TM, Walsh TF, et al.: Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging 2009, 2:299–307.CrossRefPubMed Wallace EL, Morgan TM, Walsh TF, et al.: Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. JACC Cardiovasc Imaging 2009, 2:299–307.CrossRefPubMed
68.
Zurück zum Zitat Klem I, Greulich S, Heitner JF, et al.: Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. JACC Cardiovasc Imaging 2008, 1:436–445.CrossRefPubMed Klem I, Greulich S, Heitner JF, et al.: Value of cardiovascular magnetic resonance stress perfusion testing for the detection of coronary artery disease in women. JACC Cardiovasc Imaging 2008, 1:436–445.CrossRefPubMed
69.
Zurück zum Zitat Doesch C, Seeger A, Doering J, et al.: Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging 2009, 2:424–433.CrossRefPubMed Doesch C, Seeger A, Doering J, et al.: Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imaging 2009, 2:424–433.CrossRefPubMed
70.
Zurück zum Zitat Greenwood J, Maredia N, Radjenovic A, et al.: Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. Trials 2009, 10:62.CrossRefPubMed Greenwood J, Maredia N, Radjenovic A, et al.: Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study. Trials 2009, 10:62.CrossRefPubMed
71.
Zurück zum Zitat Kirk P, Roughton M, Porter JB, et al.: Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009, 120:1961–1968.CrossRefPubMed Kirk P, Roughton M, Porter JB, et al.: Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 2009, 120:1961–1968.CrossRefPubMed
72.
Zurück zum Zitat Kim HW, Klem I, Shah DJ, et al.: Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 2009, 6:e1000057.CrossRefPubMed Kim HW, Klem I, Shah DJ, et al.: Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 2009, 6:e1000057.CrossRefPubMed
73.
Zurück zum Zitat Kwong RY, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2739.CrossRef Kwong RY, et al.: Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2739.CrossRef
74.
Zurück zum Zitat Steel K, et al.: Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009, 120:1342–1344.CrossRef Steel K, et al.: Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009, 120:1342–1344.CrossRef
Metadaten
Titel
Recent Developments in Outcomes Research in Cardiovascular MRI
verfasst von
Caroline Daly
Otavio R. Coelho-Filho
Raymond Y. Kwong
Publikationsdatum
01.06.2010
Verlag
Current Science Inc.
Erschienen in
Current Cardiovascular Imaging Reports / Ausgabe 3/2010
Print ISSN: 1941-9066
Elektronische ISSN: 1941-9074
DOI
https://doi.org/10.1007/s12410-010-9023-y

Weitere Artikel der Ausgabe 3/2010

Current Cardiovascular Imaging Reports 3/2010 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.